Pharmaceutical Chemicals & Ingredients Manufacturer | Pharma Intermediates & Contract Chemical Manufacturing Company | Active Pharmaceutical Ingredients / API Chemicals | Chemical Manufacturing Company

What we do

APIs and Intermediates:
We are a specialized pharma company focusing on niche therapeutic areas of CNS, ARVs and controlled substances. Our specialization in unique CNS segments like ADHD, Anti-psychotics, Anti-vertigo, Anti-inflammatory, Pain management, Alzheimer disease and others gives ZCL the leverage to outclass the competition. We are moving up the value chain adding capacity for more APIs.

CMO:
With the best in class manufacturing facilities with accreditation and state-of-the-art research platform besides brilliant minds in our R&D we have embarked on establishing contract manufacturing organization. We have many on-going contract manufacturing projects that involve complex chemistry and technological excellence.

Active Pharma Ingredients (APIs)

Active Pharma Ingredients (APIs)

Product	Status	Pharmacoepeia	CAS No.	Therapeutic Use	Enquiry
Apixaban	DMF*	In-house	503612-47-3	Anticoagulant
Alprazolam	Tech pack	USP/EP	28981-97-7	Anxiolytic
Aripiprazole	USDMF, CEP, KDMF	USP/EP	129722-12-9	Anti-depressant/Anti-psychotic
Atomoxetine HCl	CEP, USDMF, TDMF, IDL, CA-DMF	USP/EP	82248-59-7	Attention Deficit Hyperactivity Disorder (ADHD)
Betahistine Dihydrochloride	CEP, TDMF, CA-DMF, ANVISA, Jordan, Thailand DMF	USP/BP/EP/IP	5579-84-0	Anti-Vergo
Clozapine	USDMF, CEP*, CA-DMF	USP/EP/IP	5786-21-0	Anti-psychotic
Dapagliflozin propanediol monohydrate	USDMF	In-house	960404-48-2	Anti-diabetic
Dapsone	DMF*	USP/EP/IP	80-08-0	Anti fungal, Anti acne, Anti-leprosy
Dexmethylphenidate HCl	Tech pack	In-house	19262-68-1	Attention Deficit Hyperactivity Disorder (ADHD)
Empagliflozin	Tech pack	In-house	864070-44-0	Anti-diabetic
Eslicarbazepine Acetate	USDMF	In-house/IP	236395-14-5	Anti-epileptic
Felbinac	EDMF	BP/EP/JP	5728-52-9	Anti-inflammatory
Fluvoxamine Maleate	USDMF, CEP, TDMF	USP/BP/EP/IP	61718-82-9	Anti-depressant
Levomepromazine Maleate	CEP*, EDMF	EP	7104-38-3	Anti-psychotic
Lurasidone HCl	USDMF	In-house	367514-88-3	Anti-psychotic
Memantine HCl	USDMF, AUSDMF, KDMF, EDMF	USP/IP	41100-52-1	Alzheimer Disease
Methylphenidate HCl	CEP	USP/EP	298-59-9	Attention Deficit Hyperactivity Disorder (ADHD)
Mirabegron	Tech pack	In-house	223673-61-8	Treatment of overactive bladder
Modafinil	Tech pack	USP/EP	68693-11-8	CNS Stimulant
Olanzapine	Tech pack	USP	132539-06-1	Anti-psychotic
Pirfenidone	USDMF & CEP	In-house	53179-13-8	Anti-tablerow3 / Anti-Rheumatic
Quetiapine Fumarate	USDMF, AUSDMF, CEP & KDMF, CADMF	USP/EP	111974-72-2	Anti-psychotic
Rivaroxaban	USDMF, EDMF, CA-DMF, TDMF	In-house	366789-02-8	Anti-coagulant
Ticagrelor	Tech pack	In-house	274693-27-5	Platelet aggregaon inhibitor
Zonisamide	USDMF, JDMF*, Indonesia DMF	USP, JP	68291-97-4	Anti-convulsant
Product under development / evaluation
Bempedoic acid	Under Development	In-house	738606-46-7	Treatment of hypercholesterolemia
Cannabidiol	Under Development	In-house	13956-29-1	Anti-Epileptics
Darunavir (Amorphous)	Under Development	In-house	206361-99-1	Antiretroviral
Favipiravir	Under Development	In-house	259793-96-9	Antiretroviral
Laninamivir octanoate monohydrate	Under Development	In-house	203120-46-1	Influenza antiviral
Maraviroc	Under Development	In-house	376348-65-1	Antiretroviral
Memantine base	Under Development	In-house	19982-08-02	Alzheimer Disease
Ranolazine	Under Development	In-house	95635-55-5	Cardiovascular
Remdesivir	Under Development	In-house	1809249-37-3	Antiretroviral
Dabigatran Etexilate mesylate	Under Evalution	In-house	872728-81-9	An-Coagulant
Dabigatran Etexilate mesylate	Under Evalution	In-house	872728-81-9	Anti-Coagulant
Darunavir Ethanolate	Under Evalution	In-house	635728-49-3	Treatment of AIDS and HIV infections
Hydroxyzine HCl	Under Evalution	In-house	2192-20-3	Antihistamine
Irbesartan	Under Evalution	In-house	138402-11-6	Antihypertensive
Ivabradine HCl	Under Evalution	In-house	148849-67-6	Cardiovascular
Miglustat	Under Evalution	In-house	72599-27-0	Gaucher Disease
Olmesartan	Under Evalution	In-house	144689-63-4	Anhypertensive
Solifenacin Succinate	Under Evalution	In-house	242478-38-2	Urologicals
Telmisartan	Under Evalution	In-house	144701-48-4	Anhypertensive
Betahistine Mesylate	Tech pack	EP/JP/IP	54856-23-4	Vertigo
Cilostazol	Tech pack	USP	73963-72-1	Anti-thrombotic, Anti-platelet agent
Guanfacine HCl	Tech pack	USP	29110-48-3	Attention Deficit Hyperactivity Disorder (ADHD), Hypertension
Loxoprofen sodium	Tech pack	JP	80382-23-6	Anti-inflammatory, Analgesic
Memantine HCl	USDMF	USP	41100-52-1	Alzheimer Disease
Oxazepam	Tech pack	EP	604-75-1	Anxiolytic
Quetiapine Fumarate	USDMF* & CEP*	USP/EP	111974-72-2	Anti-psychotic
Trifluoperazine HCl	Tech pack	USP/BP/EP/IP	440-17-5	Anti-psychotic
Zaltoprofen	KDMF	JP	74711-43-6	Anti-inflammatory
Zonisamide	Tech pack	USP/EP	68291-97-4	Anti-convulsant

Brexpiprazole	Under development	in-house	913611-97-9	Antipsychotic
Bromazepam	Under Scale up	EP	1812-30-2	Anxiolytic
Eluxadoline	Under development	In-house	864821-90-9	Irritable bowel syndrome

*Under filing
Disclaimer: All transacons are carried out in conformity with the patent laws applicable in the user country.
                     Responsibility with respect to third pare’s patent rights in a specific country lies exclusively with the buyer.
                     The therapeuc use shown against each product is indicave only and is not for adversing ZCL products.
                     Patented Products are available for R&D use as per permied under 35 USC ¶ 271 (e) (1)

Advanced Intermediates

Product	CAS No.	End Use	Structure	Enquiry
Ethyl 6-(4-iodophenyl)-1-(4-methoxy phenyl)-7- oxo-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4- c]pyridine-3-carboxylate	473927-64-9	Apixaban
Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro1H-pyrazolo[3,4-c]pyridine-3-carboxylate;	503614-91-3	Apixaban
3, 3-dichloro-1-(4-iodophenyl) piperidin-2-one	545445-10-1	Apixaban
1-(2,3-Dichlorophenyl) Piperazine HCl	119532-26-2	Aripiprazole
N-Benzhydrylpiperazine	841-77-0	Cinnarizine
5-Bromo-2-chloro4'ethoxydiphenylmethane	461432-23-5	Dapagliflozin propanediol
1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,2,3,4,6-tetraacetate, (1S)- D-Glucitol	461432-25-7	Dapagliflozin propanediol
2,3,4,6-tetra-O-trimethylsilyl-ß-D-glucolactone	32384-65-9	Dapagliflozin, Empagliflozin
4,4'-sulfonylbis(nitrobenzene)	1156-50-9	Dapsone
Bis(4-nitrophenyl)sulfane	1223-31-0	Dapsone
Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2- hydroxy-4-phenylbutyl]-N-(2-methylpropyl)	169280-56-2	Darunavir
Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1- (phenylmethyl)propyl]-,1,1-dimethylethylester	191226-98-9	Darunavir, Fosamprenavir
(10S)-10,11-Dihydro-10-hydroxy-5Hdibenz[b,f]azepine-5-carboxamide	104746-04-5	Eslicarbazepine acetate
10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide	29331-92-8	Eslicarbazepine acetate
4,4'-Difluorobenzhydrylpiperazine	27469-60-9	Flunarizine
(1E)-N-Hydroxy-5-Methoxy-1-(4-Trifluoromethylphenyl)Pentan-1-Imine	61747-22-6	Fluvoxamine
2-Bromo-4'-benzyloxy-3'-nitroacetophenone	43229-01-2	Formoterol
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1- piperazinyl]phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one	252964-68-4	Itraconazole
1-Acetyl-4-(4-hydroxyphenyl) piperazine	67914-60-7	Ketoconazole
1-Acetamido 3,5-dimethyl Adamantane*	19982-07-1	Memantine
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol	391901-45-4	Mirabegron
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol	223673-34-5	Mirabegron
5-methylpyridin-2(1H)-one/2-Hydroxy-5- methylpyridine	1003- 68-5	Mirabegron
Dibenzo [b, f] [1, 4] thiazepin- 11(10H)-one	3159-07-7	Quetiapine fumarate
1-Aminoindan	34698-41-4	Rasagiline
4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride	898543-06-1	Rivaroxaban
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione	446292-08-6	Rivaroxaban
2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chlo ro-2-(propylthio)pyrimidin-4-yl)amino) -2,2-dimethyltetrahydro-3aH-cyclo penta[d][1,3]dioxol-4-yl)oxy)ethanol	376608-74-1	Ticagrelor
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate	61086-13-3	Alfentanil & Sufentanil
(1H)-7-(4’-bromobutoxy)-3,4-dihydro-2-quinolinone	1297225-34-5	Aripiprazole
3-(methylamino)-1-phenylpropan-1-ol	42142-52-9	Atomoxetine Fluoxetine Nisoxetine
N-(1,4-Benzodioxan-2-carbonyl)-piperazine	70918-00-2	Doxazosin
4-Hydroxy-3, 5-dimethyl benzonitrile	4198-90-7	Etravirine
(S)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol	1345879-87-9	Linezolid
2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid	68767-14-6	Loxoprofen Sodium
1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol hydrochloride	521284-22-0	Mirabegron
2-Methyl-10H-thieno[2,3-b][1,5] benzo diazepine-4-amine HCl	138564-60-0	Olanzapine
5-methyl-2-(2-nitrophenylamino) thiophene-3-carbonitrile	138564-59-7	Olanzapine
N-Isopropyl-4-(4-hydroxyphenyl)-piperazine	67914-97-0	Terconazole
2-(Trifluoromethyl)-phenothiazine	92-30-8	Trifluoperazine

Disclaimer: All transacons are carried out in conformity with the patent laws applicable in the user country.
                     Responsibility with respect to third pare’s patent rights in a specific country lies exclusively with the buyer.
                     The therapeuc use shown against each product is indicave only and is not for adversing ZCL products.
                     Patented Products are available for R&D use as per permied under 35 USC ¶ 271 (e) (1)

Intermediate for controlled substances

Product	CAS No.	End Use	Structure	Enquiry
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate	61086-13-3	Alfentanil & Sufentanil
N-[4-(methoxymethyl)-piperidine-4-yl]-N-phenylpropanamide monohydrochloride & Base	84196-16-7 & 61086-18-8	Alfentanil & Sufentanil
N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide Hydrochloride	5156-58-1	Fentanil
Methyl 4-(phenyl-propionyl-amino)-piperidine-4-carboxylate HCl	61085-87-8	Remifentanil
N-[4-(methoxymethyl)-piperidine-4-yl)]-N-phenylpropanamide HCl	84196-16-7	Sufentani
1-(2-bromoethyl)-4-ethyl-1,4-dihydro-5Htetrazol-5- one	84501-67-7	Alfentanil
N-[(4-methoxymethyl-1-benzyl)-4-piperidinyl]-N-phenyl propanamide monohydrochloride	84255-05-0	Alfentanil & Sufentanil
Chloromethyl cyclopropane	5911-08-0	Buprenorphine
Bromomethyl cyclopropane	7051-34-5	Buprenorphine
N-[(4-Methoxymethyl)-4-piperidinyl]-N-phenylpropanamide	61086-18-8	Sufentanil

*USDMF available

Methyl Phenidate Series

Product	CAS No.	Structure	Enquiry
Phenyl-(2-pyridyl acetamide)	7251-52-7
Phenyl-2-(2'-piperidyl)acetamide	19395-39-2
Threo phenyl-2-piperidyl acetamide*	50288-62-5
dl-threo ritalinic acid*	54631-24-2
d-threo ritalinic acid hydrohloride*	82993-81-5
dl-threo-Ritalinic acid HCl	1382859-13-3
d-threo-Ritalinic acid HCl*	741705-70-4

Under Scale-up / New Development

Product	CAS No.	End Use	Status	Structure	Enquiry
4-Amino-2-fluoro-N-methylbenzamide	915087-25-1	Apalutamide, Enzalutamide	Under scale-up
(3S)-3-[4-[(5-Bromo-2-chlorophenyl) methyl]phenoxy]tetrahydrofuran	915095-89-5	Empagliflozin	Under scale-up
(S)-(5-bromo-2-chlorophenyl)(4-((tetrahydrofuran-3-yl) oxy) phenyl)methanone	915095-84-0	Empagliflozin	Under scale-up
(5-bromo-2-chlorophenyl)(4-fluorophenylmethanone	915095-85-1	Empagliflozin	Under scale-up
(2R,3R,4R,5S,6S)-2- (acetoxymethyl)-6-(4-chloro- 3-(4-(((S)-tetrahydrofuran-3- yl)oxy)benzyl)phenyl)tetrahy dro-2Hpyran-3,4,5-triyl triacetate	915095-99-7	Empagliflozin	Under scale-up
N-Methyl-2-fluoro-4-(1,1-dimethyl cyanomethyl) aminobenzamide	915087-32-0	Enzalutamide	Under scale-up
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate	714269-58-6	Dapagliflozin propanediol	Under scale-up
2-Chloro-1-Dimethylaminopropane HC	4584-49-0	Methadone	Under development
2-(2-[3-(3-[2-(7-chloroquinolin-2-yl)ethenyl) phenyl)-3-hydroxy-npropyl]phenyl)-2-propan-1-ol	142569-70-8	Montelukast	Underscale-up
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one	6969-71-7	Trazodone	Underscale-up

Disclaimer: Users are responsible for all patent related issue for our offered products.
The therapeutic use shown against each product is indicative only and is not for advertising ZCL products.
Patented Products are available for R&D use as per permitted under 35 USC ¶ 271 (e) (1)

Disclaimer

Information given herein is offered in good faith as accurate, but without guarantee. Conditions of use and suitability of the product for particular uses are beyond our control. All risks of use of the product are therefore assumed by the user. ZCL Chemicals Limited EXPRESSLY DISCLAIMS ALL WARRANTIES OF EVERY KIND AND NATURE, INCLUDING WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE IN RESPECT TO THE USE OR SUITABILITY OF THE PRODUCT. Appropriate warnings and safe handling procedures should be provided to handlers and users.

Alteration of this document is strictly prohibited.

No statement contained herein concerning a possible or suggested use of any material, product or design is intended, or should be construed, to grant any license under any patent or other intellectual property right of ZCL Chemicals Limited or any of its associates or its affiliates covering such use or design, or as a recommendation for the use of such material, product or design in the infringement of any patent or other intellectual property right. The products are sold subject to ZCL Chemicals Limited Standard Conditions of Sale, which are available upon request.

Apixaban
Alprazolam
Aripiprazole
Atomoxetine HCl
Betahistine Dihydrochloride
Betahistine Mesylate
Bempedoic acid
Cilostazol
Dapsone
Dibenzo [b, f] [1, 4] thiazepin- 11(10H)-one
Irbesartan
Clozapine
Memantine HCl
Solifenacin Succinate
Dexmethylphenidate HCl
Eslicarbazepine Acetate
Favipiravir
Felbinac
Fluvoxamine Maleate
Guanfacine HCl
Olmesartan
Memantine base
Ivabradine HCl
5-methylpyridin-2(1H)-one/2-Hydroxy-5- methylpyridine
Levomepromazine Maleate
Loxoprofen sodium
Lurasidone HCl
Memantine HCl
Methylphenidate HCl
Mirabegron
Modafinil
Telmisartan
Olanzapine
Laninamivir
Oxazepam
Darunavir (Amorphous)
Ticagrelor
Quetiapine Fumarate
Cannabidiol
Maraviroc
Rivaroxaban
Hydroxyzine HCl
Trifluoperazine HCl
Zaltoprofen
Zonisamide
d-threo-Ritalinic acid HCl*
Brexpiprazole
Miglustat
dl-threo-Ritalinic acid HCl
Quetiapine Fumarate
Bromazepam
Dapagliflozin propanediol monohydrate
Darunavir Ethanolate
Ranolazine
Remdesivir
1-Acetamido 3,5-dimethyl Adamantane*
Eluxadoline
N-Methyl-2-fluoro-4-(1,1-dimethyl cyanomethyl) aminobenzamide
Empagliflozin
(5-bromo-2-chlorophenyl)(4-fluorophenylmethanone
Dabigatran Etexilate mesylate
Pirfenidone
(2R,3R,4R,5S,6S)-2- (acetoxymethyl)-6-(4-chloro- 3-(4-(((S)-tetrahydrofuran-3- yl)oxy)benzyl)phenyl)tetrahy dro-2Hpyran-3,4,5-triyl triacetate
(S)-(5-bromo-2-chlorophenyl)(4-((tetrahydrofuran-3-yl) oxy) phenyl)methanone
(3S)-3-[4-[(5-Bromo-2-chlorophenyl) methyl]phenoxy]tetrahydrofuran
(1H)-7-(4’-bromobutoxy)-3,4-dihydro-2-quinolinone
1-(2,3-Dichlorophenyl) Piperazine HCl
3-(methylamino)-1-phenylpropan-1-ol
N-Benzhydrylpiperazine
Bis(4-nitrophenyl)sulfane
Benzenesulfonamide, 4-amino-N-[(2R,3S)-3-amino-2- hydroxy-4-phenylbutyl]-N-(2-methylpropyl)
Carbamic acid, N-[(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1- (phenylmethyl)propyl]-,1,1-dimethylethylester
N-(1,4-Benzodioxan-2-carbonyl)-piperazine
(10S)-10,11-Dihydro-10-hydroxy-5Hdibenz[b,f]azepine-5-carboxamide
10,11-Dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide
4-Hydroxy-3, 5-dimethyl benzonitrile
4,4'-Difluorobenzhydrylpiperazine
(1E)-N-Hydroxy-5-Methoxy-1-(4-Trifluoromethylphenyl)Pentan-1-Imine
2-Bromo-4'-benzyloxy-3'-nitroacetophenone
2,4-Dihydro-4-[4-[4-(4-methoxyphenyl)-1- piperazinyl]phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one
1-Acetyl-4-(4-hydroxyphenyl) piperazine
(S)-1-chloro-3-[(4-chloro-E-benzylidene)-amino]-propan-2-ol
2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid
1R)-2-{[2-(4-aminophenyl)ethyl]amino}-1-phenylethanol hydrochloride
(1R)-2-{[2-(4-nitrophenyl)ethyl]amino}-1-phenylethanol
2-Methyl-10H-thieno[2,3-b][1,5] benzo diazepine-4-amine HCl
5-methyl-2-(2-nitrophenylamino) thiophene-3-carbonitrile
1-Aminoindan
N-[4-(methoxymethyl)-piperidine-4-yl)]-N-phenylpropanamide HCl
4,4'-sulfonylbis(nitrobenzene)
4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride
2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione
N-Isopropyl-4-(4-hydroxyphenyl)-piperazine
2-(Trifluoromethyl)-phenothiazine
1-(2-bromoethyl)-4-ethyl-1,4-dihydro-5Htetrazol-5- one
N-[1-(benzyl)-4-(methoxymethyl)-4-piperidinyl]-N-phenyl Propanamide oxalate
N-[(4-methoxymethyl-1-benzyl)-4-piperidinyl]-N-phenyl propanamide monohydrochloride
N-[4-(methoxymethyl)-piperidine-4-yl]-N-phenylpropanamide monohydrochloride
Chloromethyl cyclopropane
Bromomethyl cyclopropane
N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide Hydrochloride
Methyl 4-(phenyl-propionyl-amino)-piperidine-4-carboxylate HCl
N-[(4-Methoxymethyl)-4-piperidinyl]-N-phenylpropanamide
Phenyl-(2-pyridyl acetamide)
Phenyl-2-(2'-piperidyl)acetamide
Threo phenyl-2-piperidyl acetamide*
dl-threo ritalinic acid*
d-threo ritalinic acid hydrohloride*
1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,2,3,4,6-tetraacetate, (1S)- D-Glucitol
α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4,6-tetraacetate
2-Chloro-1-Dimethylaminopropane HC
2-(2-[3-(3-[2-(7-chloroquinolin-2-yl)ethenyl) phenyl)-3-hydroxy-npropyl]phenyl)-2-propan-1-ol
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one
2,3,4,6-tetra-O-trimethylsilyl-ß- 32384-65-9D-glucolactone
4-Amino-2-fluoro-N-methylbenzamide
5-Bromo-2-chloro4'ethoxydiphenylmethane
2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chlo ro-2-(propylthio)pyrimidin-4-yl)amino) -2,2-dimethyltetrahydro-3aH-cyclo penta[d][1,3]dioxol-4-yl)oxy)ethanol
3, 3-dichloro-1-(4-iodophenyl) piperidin-2-one
Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro1H-pyrazolo[3,4-c]pyridine-3-carboxylate
Ethyl 6-(4-iodophenyl)-1-(4-methoxy phenyl)-7-oxo-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxylate